DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer
NCT02693236
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Esophagus Cancer
Interventions
BIOLOGICAL:
adenovirus-transfected autologous DC vaccine plus CIK cells
Sponsor
Affiliated Hospital to Academy of Military Medical Sciences